Skip to main content

letter

. 1988 Apr 16;296(6629):1130. doi: 10.1136/bmj.296.6629.1130

β Blockers, lipids, and coronary atherosclerosis

H Chamsi-Pasha, R J Taylor, P C Barnes

PMCID: PMC2545532 PMID: 3132237

1130

Images in this article

p1130-a
on p.1130

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Eliasson K., Lins L. E., Rössner S. Serum lipoprotein changes during atenolol treatment of essential hypertension. Eur J Clin Pharmacol. 1981;20(5):335–338. doi: 10.1007/BF00615401. [DOI] [PubMed] [Google Scholar]
England J. D., Simons L. A., Gibson J. C., Carlton M. The effect of metoprolol and atenolol on plasma high density lipoprotein levels in man. Clin Exp Pharmacol Physiol. 1980 May-Jun;7(3):329–333. doi: 10.1111/j.1440-1681.1980.tb00078.x. [DOI] [PubMed] [Google Scholar]
Northcote R. J., Todd I. C., Ballantyne D. Beta blockers and lipoproteins: a review of current knowledge. Scott Med J. 1986 Oct;31(4):220–228. doi: 10.1177/003693308603100402. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES